This year the College offers a series of pre-recorded virtual press briefings which feature the insights of leading gastroenterology experts on several key abstracts that will be unveiled at ACG 2014 in the areas related to hepatitis C, inflammatory bowel disease, drug induced liver injury, nonalcoholic fatty liver disease, fecal microbiota transplantation and C. difficile. Notable case reports related to protein shakes, chia seeds, and other supplementation where good health intentions go bad are also featured. In these briefings, ACG experts offer their perspectives on the significance of the findings in relation to the larger issues surrounding these GI-related topics as well as tips for clinicians and patients. Links to author commentary and the abstracts are available on this page for each abstract featured in the briefings.
Fecal Microbiota Transplantation (FMT) and C. difficile
Mark Mellow, MD, FACG, provides insight on the following abstracts:
Oral 72 Fresh, Frozen, or Lyophilized Fecal Microbiota Transplantation (FMT) for Multiple Recurrent C. difficile Infection (CDI)
Read author insight and access abstract
Poster 939 Safety Outcomes After Fecal Microbiota Transplantation (FMT) For C. difficile Infection (CDI)
Read author insight and access abstract
Oral 71 C. difficile Associated Risk of Death Score (CARDS): A Novel Risk Score to Predict Mortality Among Hospitalized Patients With C. difficile Infection
Read author insight and access abstract
Poster 1639 Fecal Microbiota Transplant for Treatment of Refractory C. difficile Colitis: Long-Term Follow-Up of 58 Patients
Read author insight and access abstract
Access all ACG 2014 Press Briefings
Media Interview Requests:
Press room and video recording facilities will be available onsite. To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000.